Cardiolinc Clarissa October 13, 2017 Collaboration IMI2 call for diabetic cardiomyopathy proposals Cardiolinc Clarissa October 13, 2017 Collaboration The 13th call for proposals of the Innovative Medicines Initiatives 2 (IMI2) will open with a topic on “Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches”.